Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 10, 2013 02:10 ET | Source: Pearl Therapeutics

Pearl Therapeutics to be Acquired by AstraZeneca for up to $1.15 Billion

Redwood City, CA, June 10, 2013 (GLOBE NEWSWIRE) -- Pearl Therapeutics Inc. today announced that it has entered into a definitive merger agreement under which the Company will be acquired...
May 17, 2013 08:00 ET | Source: Pearl Therapeutics

Pearl Therapeutics Presents Dose-Ranging, Efficacy and Safety Results of PT003 as well as Components, PT001 and PT005 at American Thoracic Society Meeting

REDWOOD CITY, CALIF, May 17, 2013 (GLOBE NEWSWIRE) -- Pearl Therapeutics Inc. today announced that the Company would be presenting four posters at the upcoming annual meeting of the American Thoracic...
May 13, 2013 17:28 ET | Source: Pearl Therapeutics

Pearl Therapeutics Initiates PT003 Phase 3 Program for the Treatment of Individuals with Moderate-to-Severe COPD

Redwood City, CA, May 13, 2013 (GLOBE NEWSWIRE) -- Pearl Therapeutics Inc. today announced the initiation of PINNACLE, a global Phase 3 program of PT003, the Company's fixed-dose combination of...
March 14, 2013 08:00 ET | Source: Pearl Therapeutics

Pearl Therapeutics Receives Award for Innovative Co-Suspension Technology

REDWOOD CITY, CALIF, March 14, 2013 (GLOBE NEWSWIRE) -- Pearl Therapeutics Inc. today announced their receipt of the 2013 Drug Delivery Partnerships™ (DDP) Innovation Award for the Company's...
January 17, 2013 08:00 ET | Source: Pearl Therapeutics

Pearl Therapeutics Strengthens its Organization by Hiring Dr. Michael Riebe, an Industry Veteran in Respiratory Product Development

REDWOOD CITY, CALIF, Jan. 17, 2013 (GLOBE NEWSWIRE) -- Pearl Therapeutics Inc. today announced that Michael Riebe, Ph.D. has joined Pearl Therapeutics as vice president, pharmaceutical development and...
January 04, 2013 08:00 ET | Source: Pearl Therapeutics

Pearl Therapeutics to Present at J.P. Morgan Healthcare Conference

REDWOOD CITY, CALIF, Jan. 4, 2013 (GLOBE NEWSWIRE) -- Pearl Therapeutics Inc. today announced that Chuck Bramlage, the Company's president and CEO will be providing a corporate and clinical update at...
December 05, 2012 08:00 ET | Source: Pearl Therapeutics

Pearl Therapeutics Issued U.S. Patent on Co-Suspension Formulation Technology

REDWOOD CITY, CALIF., Dec. 5, 2012 (GLOBE NEWSWIRE) -- Pearl Therapeutics Inc. today announced that the U.S. Patent and Trademark Office has issued a patent on its novel co-suspension formulation...
November 13, 2012 07:30 ET | Source: Pearl Therapeutics

Pearl Therapeutics Raises $65 Million Series D to Start PT003 Phase 3

REDWOOD CITY, CALIF, Nov. 13, 2012 (GLOBE NEWSWIRE) -- Pearl Therapeutics Inc. today announced a $65 million Series D financing raised from current investors. 5AM Ventures, Clarus Ventures and...